A randomised evaluation of low‐dose cytosine arabinoside (ara‐C) plus tosedostat versus low‐dose ara‐C in older patients with acute myeloid leukaemia: results of the LI‐1 trial

2021 ◽  
Author(s):  
Mike Dennis ◽  
Alan Burnett ◽  
Robert Hills ◽  
Ian Thomas ◽  
Cono Ariti ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Cytosine Arabinoside ◽  
Older Patients ◽  
Low Dose ◽  
Acute Myeloid

A randomised comparison of the novel nucleoside analogue sapacitabine with low-dose cytarabine in older patients with acute myeloid leukaemia

Leukemia ◽  
2015 ◽  
Vol 29 (6) ◽  
pp. 1312-1319 ◽  
Author(s):  
A K Burnett ◽  
N Russell ◽  
R K Hills ◽  
N Panoskaltsis ◽  
A Khwaja ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Nucleoside Analogue ◽  
Older Patients ◽  
Low Dose ◽  
The Novel ◽  
Low Dose Cytarabine ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document